Skip to content

Opinion of transgender men living in Brazil on the outcomes of Masculinizing Mammoplasty

Perception of transgender men living in Brazil regarding the results of Masculinizing Mammoplasty

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-7jmc5yw
Enrollment
Unknown
Registered
2024-08-21
Start date
2024-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery, Plastic

Interventions

This is a primary, observational, cross-sectional, analytical, controlled study involving human subjects, conducted at a single center. The masculinizing mamoplasty group consists of 45 transgender me
M01.270.988

Sponsors

Universidade Federal de São Paulo
Lead Sponsor
Universidade Federal de São Paulo
Collaborator

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Transgender men living in Brazil; candidates for masculinizing mastectomy; aged 18 years or older; body mass index (BMI) between 18 and 35 kg/m2

Exclusion criteria

Exclusion criteria: Illiterate individuals or those unable to read the questionnaire; diagnosis of cognitive, neurological, or psychiatric disorder that may hinder questionnaire completion; physical disability that may prevent questionnaire completion; refusal to participate or withdrawal of consent at any stage of the study

Design outcomes

Primary

MeasureTime frame
It is expected that the scores of patients who have undergone masculinizing mastectomy will likely be higher compared to those who have not yet undergone the procedure. This assessment will be based on the Body-Q and Body Investment Scale, using the Inverse Probability Score method for comparing the means. Other variables will be compared using chi-square or Fisher's exact tests for categorical variables and the t-test for continuous variables.

Secondary

MeasureTime frame
Reduction of gender dysphoria symptoms is expected by the increase in scores of evaluated scales.

Countries

Brazil

Contacts

Public ContactGabriel Felix

Universidade Federal de São Paulo

gfelix@unifesp.br+55(11) 97535-4978

Outcome results

None listed

Source: REBEC (via WHO ICTRP)